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A B S T R A C T
We report a case of granulomatosis with polyangiitis (GPA) (Wegner's granulomatosis) who presented with
multiple mass lesions in kidneys and lung lobes, as well as neck soft tissue, mimicking malignancies. This 71-
year-old woman initially presented with sudden right foot drop, left calf pain and right eye vision loss. She was
treated with corticosteroid for the diagnosis of possible temporal arteritis. Months after steroid was tapered to
2mg per day, she developed increasing fatigue, weight loss, and shortness of breath. CT scan showed lung mass
lesions in left upper lobe (3.8× 2.4 cm), right mid lung with pleural extension (3.4× 3.3 cm), and right lower
lobe (1.1× 1.0 cm); right neck (3.3× 2.6 cm), right kidney (2.3× 1.8 cm) and left kidney (2.0× 1.6 cm). Right
quadriceps muscle biopsy shows focal granulomatous inflammation. Lung biopsy showed necrotizing and poorly
formed granulomatous inflammation. Biopsies of kidney mass lesions showed necrotizing and non-necrotizing
granulomatous inflammation. No crescentic or necrotizing glomerular lesions were observed in the total 40
sampled glomeruli. No malignancy was identified in any of the biopsies. Her c-ANCA was found to be positive
and PR3-ANCA antibody was 6.88 U/ml (normal 0–0.90 U/ml). She was diagnosed with granulomatosis with
polyangiitis and treated with high dose corticosteroid and rituximab. Eight months later, follow-up showed
resolved mass lesions by chest X-ray and CT and stable renal function. The case highlights the atypical clinical
presentation of vasculitis and the significance of considering this possibility in differential diagnosis when
confronting mass lesions present in multiple organ systems. Biopsy is critical for the correct diagnosis to initiate
timely and appropriate treatment, and also important to avoid unnecessary surgical resection.
1. Introduction
Vasculitis is a group of diseases with protean presentations, many of
which are vague and non-specific, causing broad clinical consideration
and hence challenges in reaching the correct diagnosis [1,2]. Mass le-
sions in the kidneys and lungs often raise the concern of malignancy,
while vasculitis is rarely come to differential diagnosis as a possible
cause. Occasionally unnecessary resection including lung lobectomy or
wedge resection and partial or total nephrectomy have been performed
due to the mass lesions [3,4]. Here we report a patient with multiple
mass lesions in the lungs and kidneys as well as in soft tissue of neck,
which clinically were highly suspicious for malignant neoplasms, but
pathology findings of biopsies along with additional laboratory tests are
consistent with granulomatosis with polyangiitis (GPA) (Wegner's
granulomatosis). Immunosuppressive therapy resulted in resolution of
the mass lesions.
2. Case report
A 71 year old female patient with past history of hypertension,
hypothyroidism and gastroesophageal reflux disease presented with
sudden right foot drop, left calf pain and right eye vision loss on
February 2016. Ophthalmologic examination showed right eye central
retinal artery occlusion. Chest X-ray showed that lungs were negative
with mild cardiomegaly. Biopsy on bilateral temporary artery was done
which showed mild intimal fibrosis. She was started on high dose
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prednisone for possible temporal arteritis, which gradually tapered to
2mg in February 2017. She developed increasing fatigue, weight loss,
shortness of breath, abdominal pain and lower leg pain on August 2017.
Chest CT showed solid masses in the lungs, including one in the left
upper lobe, one in the right mid lobe with pleural extension and one in
the right lower posterior lung. A partially visualized mass was also seen
on the superior pole of the right kidney. Neck CT showed a
3.3×2.6×2 cm subcutaneous lesion. Abdominal CT showed a mass in
the right superior kidney and a mass in the left inferior kidney; liver,
spleen, pancreas and adrenals appeared normal. Radiology considered
lung masses were compatible with malignant metastasis and renal mass
lesions concerning for renal cell carcinoma. The right mid lung lobe
mass and both kidney mass lesions were biopsied. Additional tests
showed c-ANCA and PR3-ANCA antibody positive. She was then diag-
nosed as GPA, and received prednisone and rituximab treatments on
October 2018.
2.1. Laboratory results
Serum creatinine 0.86mg/dl (reference range 0.6–1.2mg/dl), GFR
75.1 ml/min (> 59ml/min), CRP 102.9mg/L (0.3–5.0 mg/L), ESR
109mm/h (0–30mm/h), cryoglobulin test negative, antinuclear anti-
body negative, C3 148 mg/dl (88–201mg/dl), C4 26 mg/dl (10–40mg/
dl), c-ANCA 1:40, p-ANCA negative, atypical ANCA negative, anti-PR3
IgG 6.99 U/ml (0–0.90 U/ml), anti-MPO IgG 0.09 U/ml (0–0.90 U/ml),
tuberculosis Quantiferon Gold test negative. Urine protein 40mg/dl
(0–20mg/dl), urine protein creatinine ratio 0.18 (0–0.19), RBC 0–2/
HPF (0–2/HPF), WBC 1–5 /HPF (1–5/HPF).
2.2. Radiology results
CT of Chest on August 2017 showed a mass lesion in the left upper
lobe of lung, measuring 3.8×2.4 cm, a mass in the right mid lung with
pleural extension, measuring 3.4× 3.3 cm, and a mass in the right
lower posterior lung, measuring 1.1× 1.0 cm. Neck CT on September
2017 showed a 3.3× 2.6× 2 cm subcutaneous lesion, superficial to the
musculature in the right lateral neck. The parotid and submandibular
glands and mucosal surfaces are unremarkable. CT of Abdomen on
November 2017 showed a mass lesion in the superior lateral aspect of
right kidney measuring 2.3×1.8 cm, a second mass in the inferior pole
of left kidney measuring 2.0× 1.6 cm. Liver, spleen, pancreas and
adrenals appeared normal (see Fig. 1).
2.3. Pathology findings
The patient had biopsy of right and left temporal arteries on March
2017, which showed mild intimal fibrosis compatible with aging
changes, and negative for inflammation in serial sections. The patient
had right quadriceps skeletal muscle and sural nerve biopsies which
showed focal granulomatous inflammation, mild type II fiber atrophy
and moderate axonopathy. Right lung mass lesion biopsy showed ne-
crotizing and focally granulomatous inflammation. There is no evidence
of malignancy (see Fig. 2). Both right and left kidney mass lesions were
biopsied which showed multi-focal necrotizing and non-necrotizing
granulomatous inflammation. Vascular wall Fibrinoid necrosis or
transmural inflammation was not identified. The glomeruli showed
focal periglomerular fibrosis and compression of the glomerular capil-
lary tufts, but no crescentic lesions or fibrinoid necrosis were observed
in total 40 glomeruli. There was no infiltration of eosinophils or neu-
trophils (see Fig. 3). Grocott-Gomori methenamine stain and Ziehl-
Neelsen stain did not reveal fungal or mycobacterial microorganisms,
respectively. Immunohistochemical stain for cytomegalovirus and
adenovirus are both negative. There was no kidney tissue submitted for
immunofluorescence or electron microscopic studies. There is no evi-
dence of malignancy in both kidney biopsies.
2.4. Therapy and follow-up
After the diagnosis of GPA, the patient received rituximab 1000mg
twice (two weeks apart) on October 2017, then 1000mg on April 2018,
with plan of maintenance treatment 500mg per 6months for two years.
The patient received prednisone 40mg daily from October 2017, then
tapered until off on the end of Mach 2018. On the last follow up (August
2018), the patient had no symptoms, specifically, no shortness of
breath, no cough, no hemoptysis, no hematuria, no fever or fatigue and
no weight loss. Physical examination showed blood pressure 120/
74mmHg, no rashes or subcutaneous mass lesions, lungs clear, ab-
domen soft and non-tender, and extremities no edema. Lab tests showed
serum creatinine 1.2 mg/dl, c-ANCA and p-ANCA negative, atypical
ANCA indeterminate, anti-PR3-IgG 0.9 U/ml, anti-MPO IgG 0.1 U/ml,
ESR 19mm/h, CRP < 1.0mg/L. Chest X-ray on May 2018 showed that
lungs were clear, no pleural effusion, no mass lesions in the lungs or
chest wall, cardiac silhouette size mildly enlarged. Chest CT performed
on September 2018 showed focal small scar-like changes in the areas of
pervious lung mass lesions (see Fig. 1).
3. Discussion
Vasculitides are a group of diseases defined as inflammation of
blood vessels with structural injury, necrosis or occlusion of the vessels
[5,6]. The presentation of vasculitis can be very non-specific and differs
considerably from patient to patient due to its variable involvement of
the vascular systems in different organs, which makes its often diag-
nostically challenging. Vasculitis can manifest as organ-specific but
more often demonstrates multisystemic involvement. Large vessel vas-
culitis including Takayasu arteritis and giant cell arteritis shows gran-
ulomatous arteritis and is localized to aorta and its major branches.
Polyarteritis nodosa and Kawasaki disease involves medium-sized and
small arteries. Small vessel vasculitis (SVV) involves small arteries,
capillaries and venules. It can be primary, but can also be secondary to
other systemic disease such as systemic lupus erythematosus (SLE),
rheumatoid arthritis, Henoch-Schönlein purpura or cryoglobulinemia.
Non-immune complex-mediated SVV is also called pauci-immune vas-
culitis. The majority of pauci-immune SVV are associated with anti-
neutrophilic cytoplasmic antibody (ANCA), which is related to a variety
of autoantigens including myeloperoxidase (MPO), proteinase-3 (PR3),
lysosomal membrane protein 2 (LAMP2), elastase, and others [7]. The
major forms of ANCA-associated small vessel vasculitis encompass mi-
croscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA)
(Wegner's granulomatosis) and eosinophilic granulomatosis with poly-
angiitis (EGPA) (Churg-Strauss), separated by integrated clinical and
pathological findings [2,8].
The organ systems involved by GPA most commonly are upper re-
spiratory tract including nasal cavity and nasal sinuses, lungs and kid-
neys. Upper airway symptoms including sinusitis, recurrent epistaxis,
mucosal ulceration, nasal septal perforation, are responsible for pre-
sentation symptoms in 73% of patients in a large study of 158 cases [9].
However, many patients, including our patient do not have upper re-
spiratory symptoms. Vasculitis can present as mononeuritis multiplex,
which was likely the cause of sudden right foot drop and left calf pain in
this patient at presentation. The etiology of sudden right eye vision loss
might be obliterative vasculitis associated with GPA which showed
central retinal artery occlusion by ophthalmologic examination. Pul-
monary symptoms of GPA include cough, hemoptysis, shortness of
breath and chest pain (pleuritis), and radiology may show lung in-
filtrates in 45% of patients. Occasionally lung changes can present as
distinct mass lesion(s), which closely mimics neoplastic process. Biopsy
is important for diagnosis before considering lobectomy or wedge re-
section, which may further compromise the lung function. However,
interpretation of the lung biopsy in these patients can be very chal-
lenging. It may only show focal acute and chronic inflammation. The
finding of focal acute inflammation is the subsequent response to the
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necrosis instead of due to infection. But the more suggestive feature of
granulomatous inflammation can be very vague and very poorly
formed. In addition, the characteristic necrotizing granulomatous
change can be very focal and may not well sampled. Therefore, the
biopsy findings can be misinterpreted as an infectious process or as
aspiration pneumonitis. The latter was suggested in the comment of the
lung biopsy report of this case. Therefore, it is important to pay close
attention to the histiocytic clusters and small focus of necrosis which
Fig. 1. Radiology imaging (CT) of chest and abdomen: A–C: Before biopsy and treatment in 2017: A. Chest CT shows an anterior mid lung mass (straight arrow) and
lower posterior lung nodule (curved arrow). The posterior nodule has central hypodensities suggestive of cavitation. B. Chest CT shows large right mid lateral lung
mass with pleural extension (straight arrow) corresponding with the anterior mass on previous picture, and an irregular mass of the left lung apex (curved arrow). C.
Abdominal CT shows right upper pole (straight arrow) and left lower pole (curved arrow) renal mass lesions. D-F: Chest CT in 2019 after prednisone and rituximab
treatment: D. Previous sites of right anterior mid mass (straight arrow) and lower posterior nodule (curved arrow) show that they have resolved with a small amount
of residual scarring at the sites. E. Previous sites of right lung mid lateral mass (straight arrow) and left apex mass (curved arrow) show that they have resolved with a
small amount of residual scarring at the sites. F. 2019 chest CT– Contour deformity of the upper pole of right kidney at the site of the previous mass lesion (straight
arrow), consistent with cortical scarring. The mass is no longer seen. There is no abdominal CT from 2019, and this is the best image available to look at the renal
lesions seen in 2017. The left lower pole kidney is not included in the CT field of view.
Fig. 2. lung biopsy (hematoxylin and eosin stains): A
and C: intermediate power views show necrosis and
acute inflammation (straight arrows), and vague
granulomatous inflammation with multi-nucleated
giant cells (curved arrows). B and D: high power
views show necrosis and acute inflammation
(straight arrows), and granulomatous inflammation
with multi-nucleated giant cells (curved arrows).
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would give a hint for the diagnosis of necrotizing granulomatous in-
flammation. Special stains for fungal or mycobacterial organisms, or
viral immunohistochemical stains can be used to rule out other causes
of necrotizing granulomatous inflammation such as fungal, myco-
bacterial or viral infection. Polarization microscopy may be applied to
rule out foreign material. Clinical and radiologic correlation can be also
important. Keeping an open mind with broad differential diagnosis is
essential. Base on the pathologic finding, the pathologist can offer
suggestions for additional workup such as serology tests, so as to obtain
further supportive evidence to reach a definite diagnosis.
The characteristic finding from kidney biopsy in patients of GPA is
most often pauci-immune necrotizing crescentic glomerulonephritis
[10]. Vasculitis outside of glomerular capillary tufts is seen in 8% to
13%, and granulomatous changes are seen in about 3% [9,11]. Very
rarely, a renal mass lesion is reported [3,4,12]. The kidney biopsy of
our patient demonstrates no glomerular changes such as fibrinoid ne-
crosis or crescentic lesions. In the 40 sampled glomeruli, the glomerular
tufts are either intact with no significant change or show compression
by surrounding extraglomerular inflammation and fibrosis. This pa-
tient's urinalysis shows minimal hematuria or proteinuria with normal
or near normal renal function, which is consistent with the pathologic
findings of no glomerular involvement by vasculitis. The kidney mass
lesions showed multifocal necrotizing and non-necrotizing granuloma-
tous inflammation in the interstitium. Definite arterial or arteriolar fi-
brinoid necrosis or transmural inflammation is not identified. The dif-
ferential diagnosis for kidney granulomatous inflammation is broad,
which can include infection, drug reaction, autoimmune processes,
sarcoidosis, among others. There is no interstitial infiltration of eosi-
nophils which argues against a drug reaction. The stains for infectious
agents such as fungal, mycobacterial, CMV and adenovirus infection are
also negative. In this patient with c-ANCA and PR3-ANCA antibody
positivity, the biopsies of lung, kidneys and quadriceps showed similar
granulomatous inflammation. Putting the clinical, laboratory and pa-
thological findings together, it is most consistent with a diagnosis of
GPA which manifested as multiple mass lesions in organs and soft
tissue.
Mass lesions in vasculitis have been reported in the lung, nasal
sinus, mediastinum, kidney and even brain. In this patient, multiple
mass lesions involving lungs, kidneys, and neck soft tissue are
particularly remarkable. Clinically and radiologically these lesions can
well mimic malignant neoplasm with metastasis. It has been reported
that resections including wedge excision or lobectomy for lung mass,
and total or partial nephrectomy for kidney mass have been performed
for these lesions, which can be detrimental to the organ function
[3,4,12]. Therefore, it is important to know the unusual presentations
of vasculitides and keep them in the differential diagnosis clinically and
pathologically. Biopsy plays a significant role for the diagnosis which
may help initiate appropriate medical therapy. Proper and timely
treatment often results in complete resolution of the mass lesions in
these patients, which happened in our patient.
4. Conclusion
The presentation of granulomatosis with polyangiitis can be very
unusual, including multiple mass lesions in organs and soft tissue, mi-
micking malignant neoplasms with metastasis. Knowledge of its un-
common presentations can help broaden the radar of clinical thought
process so that vasculitis may be considered among the differential
diagnosis. Perform relevant laboratory tests and biopsy for pathologic
examination will help establish the correct diagnosis, initiate timely
and appropriate treatment, and also importantly, avoid unnecessary
surgery of resection which may compromise organ function.
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